CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 159 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $707,000 | -57.4% | 3,573,276 | -3.0% | 0.00% | -100.0% |
Q3 2018 | $1,661,000 | -23.0% | 3,683,389 | -14.0% | 0.00% | 0.0% |
Q2 2018 | $2,156,000 | -77.8% | 4,281,328 | +2.7% | 0.00% | -75.0% |
Q1 2018 | $9,710,000 | +43.4% | 4,167,585 | +74.8% | 0.00% | +33.3% |
Q4 2017 | $6,771,000 | +174.7% | 2,383,820 | +176.6% | 0.00% | +200.0% |
Q3 2017 | $2,465,000 | +19.9% | 861,790 | +3.6% | 0.00% | 0.0% |
Q2 2017 | $2,056,000 | +15.6% | 832,186 | +69.0% | 0.00% | 0.0% |
Q1 2017 | $1,778,000 | +437.2% | 492,547 | +426.4% | 0.00% | – |
Q4 2016 | $331,000 | -1.5% | 93,569 | +12.5% | 0.00% | – |
Q3 2016 | $336,000 | +253.7% | 83,142 | +284.9% | 0.00% | – |
Q2 2016 | $95,000 | +58.3% | 21,600 | +36.6% | 0.00% | – |
Q1 2016 | $60,000 | +445.5% | 15,816 | +2536.0% | 0.00% | – |
Q4 2014 | $11,000 | -99.5% | 600 | -99.6% | 0.00% | -100.0% |
Q3 2014 | $2,143,000 | -82.6% | 165,385 | -78.1% | 0.00% | -77.8% |
Q2 2014 | $12,329,000 | -26.9% | 755,433 | -20.9% | 0.01% | -30.8% |
Q1 2014 | $16,874,000 | -38.6% | 954,784 | -15.9% | 0.01% | -38.1% |
Q4 2013 | $27,483,000 | -31.8% | 1,135,258 | -0.2% | 0.02% | -40.0% |
Q3 2013 | $40,299,000 | +121.1% | 1,137,412 | -2.6% | 0.04% | +105.9% |
Q2 2013 | $18,223,000 | – | 1,167,429 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |